Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages

衰老细胞通过激活CD38+巨噬细胞促进组织中NAD+的减少。

阅读:5
作者:Anthony J Covarrubias ,Abhijit Kale # ,Rosalba Perrone # ,Jose Alberto Lopez-Dominguez ,Angela Oliveira Pisco ,Herbert G Kasler ,Mark S Schmidt ,Indra Heckenbach ,Ryan Kwok ,Christopher D Wiley ,Hoi-Shan Wong ,Eddy Gibbs ,Shankar S Iyer ,Nathan Basisty ,Qiuxia Wu ,Ik-Jung Kim ,Elena Silva ,Kaitlyn Vitangcol ,Kyong-Oh Shin ,Yong-Moon Lee ,Rebeccah Riley ,Issam Ben-Sahra ,Melanie Ott ,Birgit Schilling ,Morten Scheibye-Knudsen ,Katsuhiko Ishihara ,Stephen R Quake ,John Newman ,Charles Brenner ,Judith Campisi ,Eric Verdin

Abstract

Declining tissue nicotinamide adenine dinucleotide (NAD) levels are linked to ageing and its associated diseases. However, the mechanism for this decline is unclear. Here, we show that pro-inflammatory M1-like macrophages, but not naive or M2 macrophages, accumulate in metabolic tissues, including visceral white adipose tissue and liver, during ageing and acute responses to inflammation. These M1-like macrophages express high levels of the NAD-consuming enzyme CD38 and have enhanced CD38-dependent NADase activity, thereby reducing tissue NAD levels. We also find that senescent cells progressively accumulate in visceral white adipose tissue and liver during ageing and that inflammatory cytokines secreted by senescent cells (the senescence-associated secretory phenotype, SASP) induce macrophages to proliferate and express CD38. These results uncover a new causal link among resident tissue macrophages, cellular senescence and tissue NAD decline during ageing and offer novel therapeutic opportunities to maintain NAD levels during ageing.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。